Ian W Flinn Selected Research

Ian W Flinn Research Topics

Disease

57	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 11/2023 - 02/2002
39	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2024 - 02/2002
29	Neoplasms (Cancer) 01/2024 - 02/2002
22	Lymphoma (Lymphomas) 11/2023 - 09/2002
20	Neutropenia 10/2023 - 09/2011
18	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 10/2022 - 02/2004
13	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 05/2022 - 02/2010
12	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2023 - 01/2005
11	Infections 07/2023 - 08/2003
10	Disease Progression 10/2023 - 08/2004
10	Diarrhea 05/2022 - 03/2014
9	B-Cell Lymphoma (Lymphoma, B Cell) 11/2023 - 04/2007
9	Pneumonia (Pneumonitis) 04/2021 - 03/2014
7	Fatigue 01/2023 - 04/2007
7	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 06/2013
7	Thrombocytopenia (Thrombopenia) 01/2021 - 03/2007
6	Febrile Neutropenia 05/2022 - 12/2014
6	Leukemia 01/2019 - 02/2002
4	Residual Neoplasm 01/2023 - 01/2019
4	Nausea 12/2018 - 05/2014
4	Exanthema (Rash) 11/2018 - 09/2011
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 07/2021 - 06/2013
3	Hodgkin Disease (Hodgkin's Disease) 01/2021 - 08/2004
3	Multiple Myeloma 01/2021 - 01/2011
3	Colitis 01/2019 - 12/2016
3	Fever (Fevers) 12/2018 - 04/2007
3	Anemia 12/2018 - 05/2014
2	Hemorrhage 07/2023 - 01/2017
2	Lymphocytosis 07/2023 - 03/2013
2	Atrial Fibrillation 07/2023 - 04/2021
2	Hypertension (High Blood Pressure) 07/2023 - 01/2022
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2023 - 06/2021
2	Sepsis (Septicemia) 04/2021 - 03/2017
2	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 04/2021 - 03/2017
2	Body Weight (Weight, Body) 01/2020 - 12/2017
2	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 10/2019 - 08/2003
2	Tumor Lysis Syndrome 01/2019 - 12/2014
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2019 - 10/2017
2	Vomiting 04/2016 - 05/2014
2	Lymphadenopathy 05/2014 - 03/2013
2	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2007 - 04/2006
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 11/2023

Drug/Important Bio-Agent (IBA)

44	Rituximab (Mabthera)FDA Link 10/2023 - 02/2002
19	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2021 - 08/2003
18	ibrutinibIBA 01/2024 - 07/2013
15	Bendamustine Hydrochloride FDA Link 01/2022 - 05/2014
12	fludarabineIBA 11/2018 - 02/2002
11	idelalisibIBA 01/2021 - 03/2013
10	Monoclonal AntibodiesIBA 10/2023 - 02/2002
10	Prednisone (Sone)FDA LinkGeneric 01/2021 - 08/2003
10	Vincristine (Oncovin)FDA LinkGeneric 01/2021 - 08/2003
9	Agammaglobulinaemia Tyrosine KinaseIBA 07/2023 - 05/2015
9	obinutuzumabIBA 01/2022 - 01/2019
9	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 08/2003
8	Chlorambucil (Leukeran)FDA Link 01/2022 - 05/2006
7	ofatumumab FDA Link 01/2019 - 01/2016
6	Transaminases (Aminotransferases)IBA 12/2021 - 03/2014
6	ibritumomab tiuxetan (Zevalin)FDA Link 06/2021 - 02/2002
5	Chimeric Antigen ReceptorsIBA 11/2023 - 12/2017
5	axicabtagene ciloleucelIBA 11/2023 - 12/2017
5	venetoclaxIBA 07/2023 - 01/2019
5	YttriumIBA 06/2021 - 02/2002
5	duvelisibIBA 12/2019 - 01/2018
4	acalabrutinibIBA 01/2024 - 01/2020
4	zanubrutinibIBA 01/2024 - 10/2020
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2003
3	AntibodiesIBA 10/2023 - 08/2003
3	Lenalidomide (CC 5013)FDA Link 10/2022 - 01/2018
3	Phosphatidylinositols (Phosphatidylinositol)IBA 12/2021 - 05/2014
3	umbralisibIBA 12/2021 - 01/2018
3	nilotinib FDA Link 07/2021 - 09/2011
3	Imatinib Mesylate (Gleevec)FDA Link 07/2021 - 09/2011
3	Bortezomib (Velcade)FDA Link 01/2018 - 09/2006
3	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2018 - 05/2014
3	Interleukin-2 (IL2)IBA 10/2007 - 12/2005
2	pirtobrutinibIBA 07/2023 - 01/2021
2	Azacitidine (5 Azacytidine)FDA Link 01/2023 - 04/2004
2	brexucabtagene autoleucelIBA 01/2023 - 01/2020
2	3- (5- amino- 2- methyl- 4- oxoquinazolin- 3(4H)- yl)piperidine- 2,6- dioneIBA 05/2022 - 02/2022
2	carfilzomibIBA 01/2021 - 05/2015
2	PanobinostatIBA 01/2021 - 05/2015
2	Phosphotransferases (Kinase)IBA 01/2021 - 05/2014
2	enasidenibIBA 01/2019 - 10/2017
2	R-CHOP protocolIBA 01/2019 - 02/2010
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 12/2018 - 05/2014
2	Alanine Transaminase (SGPT)IBA 01/2018 - 05/2014
2	Alkylating AgentsIBA 01/2017 - 03/2014
2	TRU 016IBA 01/2015 - 02/2014
2	Immunoglobulins (Immunoglobulin)IBA 06/2014 - 02/2004
2	lumiliximabIBA 01/2010 - 08/2007
2	Alemtuzumab (Campath)FDA Link 01/2005 - 05/2004
2	Complement System Proteins (Complement)IBA 04/2003 - 02/2002
1	Bispecific AntibodiesIBA 03/2024

Therapy/Procedure

42	Therapeutics 11/2023 - 03/2002
17	Drug Therapy (Chemotherapy) 10/2022 - 02/2002
6	Radioimmunotherapy 06/2021 - 02/2002
4	Stem Cell Transplantation 01/2022 - 03/2002
4	Transplantation 10/2007 - 01/2005
2	Duration of Therapy 07/2023 - 01/2023
2	Immunotherapy 01/2018 - 06/2014